Document Detail

Safety assessment of biopharmaceuticals: Japanese perspective on ICH S6 guideline maintenance.
MedLine Citation:
PMID:  18670158     Owner:  NLM     Status:  MEDLINE    
Safety assessment of biopharmaceuticals in preclinical studies is guided by the ICH S6 guideline issued in 1997. Along with enormous experiences and knowledge on safety assessment of some classes of biopharmaceuticals over the last decade, the necessity and feasibility of updating the guideline has been discussed. According to a recommendation by safety experts at the ICH meeting in Chicago in 2006, regional discussions of ICH S6 were held in the USA, EU and Japan. The meeting to clarify the values, challenges and recommendations for ICH S6 from Japanese perspective was held as a part of the first Drug Evaluation Forum in Tokyo on August 10, 2007. Of utmost importance, the "case-by-case" approach must be preserved as the basic principle of the ICH S6 guideline. It is our opinion that oligonucleotides, siRNA, aptamers and related molecules should be excluded from ICH S6 and may be more appropriate for separate guidance. However, based on experiences and accumulated knowledge, there are a number of issues that can be updated including new types of biopharmaceuticals such as bioconjugates, use of homologous proteins and transgenic animals, reproductive/developmental toxicity studies in non-human primates, in vitro cardiac ion channel assay and alternative approaches for carcinogenicity assessment. Preliminary recommendations for some of these topics were outlined at the meeting. The overall Japanese recommendation is that the ICH S6 guideline should be updated to address these topics.
Takahiro Nakazawa; Misao Kurokawa; Kazuya Kimura; Akihiro Wakata; Shigeru Hisada; Tadashi Inoue; Fumio Sagami; Shawn M Heidel; Koji Kawakami; Kazutoshi Shinoda; Hiroshi Onodera; Yuji Kumagai; Yasuo Ohno; Nobuyuki Kawamura; Tsuneyoshi Yamazaki; Tohru Inoue
Related Documents :
19166178 - Safety of patient meals in 2 hospitals in alexandria, egypt before and after training o...
4346978 - Microbiological testing of skylab foods.
16637668 - Need for an "integrated safety assessment" of gmos, linking food safety and environment...
19965358 - Information system equality for food security--implementation of the food safety contro...
16812288 - Foraging in a simulated natural environment: there's a rat loose in the lab.
24680078 - Impact of traditional practices on food safety: a case of acute toxoplasmosis related t...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The Journal of toxicological sciences     Volume:  33     ISSN:  1880-3989     ISO Abbreviation:  J Toxicol Sci     Publication Date:  2008 Aug 
Date Detail:
Created Date:  2008-08-01     Completed Date:  2008-10-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7805798     Medline TA:  J Toxicol Sci     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  277-82     Citation Subset:  IM    
Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-clinical Evaluation Subcommittee, Tokyo.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Products / toxicity*
Biotechnology / methods*
Carcinogenicity Tests
Dose-Response Relationship, Drug
Drug Evaluation, Preclinical / methods*
Fetus / drug effects
Guidelines as Topic*
International Cooperation
Reproduction / drug effects
Reg. No./Substance:
0/Biological Products

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Endocrine disruption induced by organotin compounds; organotins function as a powerful agonist for n...
Next Document:  Pesticide resistance in wild mammals--mechanisms of anticoagulant resistance in wild rodents.